WT1 Expression in Patients with Myelodysplastic Syndromes: A Variety of Possibilities in Future al kali Practice

被引:1
|
作者
Ogata, Kiyoyuki [1 ]
机构
[1] Metropolitan Res & Treatment Ctr Blood Disorders, Tokyo, Japan
关键词
TUMOR GENE WT1; PERIPHERAL-BLOOD; MESSENGER-RNA; BONE-MARROW; CELLS;
D O I
10.1159/000449363
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:30 / 31
页数:2
相关论文
共 50 条
  • [31] Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?
    Saatci, Cetin
    Caglayan, A. Okay
    Kocyigit, Ismail
    Akalin, Hilal
    Kaynar, Leyla G.
    Altuntas, Fevzi
    Eser, Bulent
    Demir, Muzaffer
    Cetin, Mustafa
    Ozkul, Yusuf
    HEMATOLOGY, 2010, 15 (01) : 39 - 42
  • [32] Expression of WT-1 mRNA in Peripheral Blood from Myelodysplastic Syndromes
    Tamura, Hideto
    Dan, Kazuo
    Yokose, Norio
    Iwakiri, Rika
    Ohta, Masatsugu
    Sakamaki, Hisashi
    Tohyama, Kaoru
    Kondo, Asaka
    Nakamura, Kyoko
    Yamashita, Taishi
    Tsuji, Takashi
    Ogata, Kiyoyuki
    BLOOD, 2008, 112 (11) : 1244 - 1244
  • [33] WT1 gene expression:: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader, P
    Niemeyer, C
    Weber, G
    Coliva, T
    Rossi, V
    Kreyenberg, H
    Gerecke, A
    Biondi, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (01) : 25 - 28
  • [34] Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome
    Ueda, Yasunori
    Ogura, Michinori
    Miyakoshi, Shigesaburo
    Suzuki, Takahiro
    Heike, Yuji
    Tagashira, Shuzo
    Tsuchiya, Satoru
    Ohyashiki, Kazuma
    Miyazaki, Yasushi
    CANCER SCIENCE, 2017, 108 (12): : 2445 - 2453
  • [35] Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome
    Nagasaki, Joji
    Aoyama, Yasutaka
    Hino, Masayuki
    Ido, Kentaro
    Ichihara, Hiroyoshi
    Manabe, Masahiro
    Ohta, Tadanobu
    Mugitani, Atsuko
    ACTA HAEMATOLOGICA, 2017, 137 (01) : 32 - 39
  • [36] In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes:: increase in cytotoxicity and reduction in WT1 gene expression
    Pan, L
    Ohnishi, K
    Zhang, WJ
    Yoshida, H
    Maksumova, L
    Muratkhodjaev, F
    Shigeno, K
    Nakamura, S
    Luo, JM
    Hao, HL
    Fujisawa, S
    Naito, K
    Shinjo, K
    Takeshita, A
    Ohno, R
    LEUKEMIA, 2000, 14 (09) : 1634 - 1641
  • [37] WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes
    Galimberti, Sara
    Ghio, Francesco
    Guerrini, Francesca
    Ciabatti, Elena
    Grassi, Susanna
    Ferreri, Maria Immacolata
    Petrini, Mario
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (03) : 451 - 454
  • [38] In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes: increase in cytotoxicity and reduction in WT1 gene expression
    L Pan
    K Ohnishi
    WJ Zhang
    H Yoshida
    L Maksumova
    F Muratkhodjaev
    K Shigeno
    S Nakamura
    JM Luo
    HL Hao
    S Fujisawa
    K Naito
    K Shinjo
    A Takeshita
    R Ohno
    Leukemia, 2000, 14 : 1634 - 1641
  • [39] WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine
    Falconi, Giulia
    Fabiani, Emiliano
    Ottone, Tiziana
    Piciocchi, Alfonso
    Lavorgna, Serena
    Criscuolo, Marianna
    Fianchi, Luana
    Gurnari, Carmelo
    Postorino, Massimiliano
    Picardi, Alessandra
    Palmieri, Raffaele
    Lo-Coco, Francesco
    Voso, Maria Teresa
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 979 - 982
  • [40] Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow
    van Dijk, JP
    Knops, GHJN
    van de Locht, LTF
    Menke, AL
    Jansen, JH
    Mensink, EJBM
    Raymakers, RAP
    de Witte, T
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) : 1027 - 1033